Adjusted operating margin improved by 40 basis points year-over-year to 15.6%, on track to achieve 20 to 40 basis points margin expansion goal for 2025.
Belcan acquisition contributed approximately 400 basis points of inorganic growth.
Financial Services grew 6% year-over-year, led by digital engineering, legacy modernization, and vendor consolidation initiatives.
Headcount grew about 2% sequentially, led by hiring recent college graduates; voluntary attrition for tech services declined by 60 basis points sequentially to 15.2%.
Health Sciences grew 5% year-over-year despite near-term discretionary demand pressures from Medicaid changes and tariffs.
Q2 bookings grew 18% year-over-year, with trailing 12 months growth of 6%, including 6 large deals with TCV of $100 million or greater and 2 mega deals valued around $1 billion each.
Returned $521 million of capital to shareholders in Q2, with $885 million returned in the first half of 2025.
Revenue grew across all major regions with North America leading at 8%, Europe at 4%, and Rest of World at about 6%.
Second quarter free cash flow was $331 million compared to $183 million a year ago.
Second quarter revenue grew 7.2% year-over-year in constant currency to $5.2 billion, marking the fourth consecutive quarter of year-over-year organic growth.